| ¿µ¹® | social phobia | ÇÑ±Û | »çȸ°øÆ÷ |
|---|---|---|---|
| ¼³¸í | ´Ù¸¥ »ç¶÷µéÀÌ Àڱ⸦ »ìÇǰí ÃÄ´Ù º¼¼ö ÀÖ´Â »óȲÀ» µÎ·Á¿öÇÏ°í ±×·± »óȲ¿¡ óÇÏ¸é ¼öÄ¡½ÉÀ» ´À³¢´Â °øÆ÷Àå¾Ö(phobic disorder)ÀÇ ÀÏÁ¾. »ç¶÷À» ¸¸³ª±â Àü¿¡ ¹Ì¸® ¿¹»óÇÏ°í ºÒ¾È(anticipatory anxiety: ¿¹»óÀ» ÇÏ´Â °Í ÀÚü¸¸À¸·Î ºÒ¾ÈÀ» ´À³¢´Â °Í)À» ½ÉÇÏ°Ô ´À³¢¹Ç·Î »ç¶÷°ú Á¢ÃËÇÏ´Â °ÍÀ» ÇÇÇÑ´Ù. ÈçÇÑ »çȸ °øÆ÷ÁõÀ¸·Î´Â »ç¶÷¾Õ¿¡¼ ¸»Çϱ⸦ µÎ·Á¿öÇÏ´Â ´ëȰøÆ÷(fear of public speaking), »ç¶÷¾Õ¿¡¼ ¾ó±¼À» ºÓÈ÷´Â °ÍÀ» µÎ·Á¿öÇÏ´Â Àû¸é°øÆ÷(erythrophobia), »ç¶÷ ¾Õ¿¡¼ÀÇ ½Ä»ç¸¦ µÎ·Á¿öÇÏ´Â ½Ä»ç°øÆ÷(sitophobia), »ç¶÷ ¾Õ¿¡¼ÀÇ ±Û ¾²±â¸¦ µÎ·Á¿öÇÏ´Â ¼ÇʰøÆ÷, °øÁߺ¯¼Ò¸¦ »ç¿ëÇϱ⸦ µÎ·Á¿öÇÏ´Â °øÁߺ¯¼Ò°øÆ÷µîÀÌ ÀÖÀ½. ÀÌ Àå¾Ö´Â ¾Æµ¿±â ÈÄ¹Ý È¤Àº »çÃá±â Ãʹݿ¡ ½ÃÀÛµÇ¸ç °¡Á·ÀûÀ¸·Î ¹ßº´ÇÏ´Â °æÇâÀÌ ¸¹´Ù. ÇÕº´ÁõÀ¸·Î´Â °úÀ½, Ç×ºÒ¾È ¾à¹° ³²¿ë µîÀÌ ÀÖ´Ù. |
||
| MSW | Master of Social Welfare; Master of Social Work; medical social worker; multiple stab wounds |
|---|---|
| IPT | Interpersonal Psycho-Therapy |
| ICD | I-cell disease; immune complex disease; implantable cardioverter defibrillator; impulse-control diso... |
| ICD-10 | International Statistical Classification of Diseases and Health-related Problems, 10th revision |
| STANDOUT | soft thresholding and depth cueing of unspecified techniques |
| WPSI | Washington Psycho-Social Seizure Inventory |
|---|---|
| DRP | Drug Related Problems |
| ICHPPC | International Classification of Health Problems in Primary Care |
| IIP | Inventory of Interpersonal Problems |
| DHSS | Department of Health and Social Security |
relation (À§Ä¡, °ü°è
| social problems | Situations affecting a significant number of people, that are believed to be sources of difficulty or threaten the stability of the community, and that require programs of amelioration. (12 Dec 1998) |
|---|---|
| psycho- | <prefix> A combining form from Gr. The soul, the mind, the understanding; as, psychology. (29 Oct 1998) |
| psycho-oncology | The psychological aspects of the treatment and management of the patient with cancer; it combines elements of psychiatry, psychology, and medicine with special concern for the psychosocial needs of the patient and his/her family. (05 Mar 2000) |
| International Classification of Health Problems in Primary Care | A classification of diseases, conditions and problems arranged for use in primary care where diagnostic precision is seldom possible. (05 Mar 2000) |
| adhesion-related kinase | <chemical> New member of the immunoglobulin superfamily with 2 immunoglobulin-like domains Synonym: ark protein, ark receptor tyrosine kinase (26 Jun 1999) |
| age-related macular degeneration | A common macular degeneration beginning with drusen of the macula and pigment disruption and sometimes leading to severe loss of central vision. (05 Mar 2000) |
| aids-related complex | A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating aids-related complex (arc) from aids include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in aids; follicular or mixed hyperplasia in arc lymph nodes, leading to lymphocyte degeneration and depletion more typical of aids; evolving succession of histopathological lesions such as localization of kaposi's sarcoma, signaling the transition to the full-blown aids. (12 Dec 1998) |
| aids-related opportunistic infections | Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include pneumocystis carinii pneumonia, kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with mycobacterium avium complex, microsporidium, and cytomegalovirus. (12 Dec 1998) |
| AIDS-related virus | An obsolete term for human immunodeficiency virus. (05 Mar 2000) |
| alcohol-related disorders | Mental disorders related or resulting from abuse or mis-use of alcohol. (12 Dec 1998) |
| amphetamine-related disorders | Disorders related or resulting from use of amphetamines. (12 Dec 1998) |
| angiotensin-related carboxypeptidase | <enzyme> Rat and bovine brain synaptosomal enzyme can hydrolyze angiotensin I to des-leu angiotensin I, but no further Registry number: EC 3.4.- Synonym: angiotensin-specific carboxypeptidase (26 Jun 1999) |
| calcitonin gene-related peptide | <protein> A second product transcribed from the calcitonin gene. Calcitonin gene related peptide is found in a number of tissues including nervous tissue. It is a vasodilator that may participate in the cutaneous triple response. It is a neuropeptide of 37 amino acids with structural homology to salmon calcitonin. Co-localises with substance P in neurons. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in neural tissue of the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator. Intracerebral administration leads to a rise in noradrenergic sympathetic outflow, a rise in blood pressure and a fall in gastric secretion. Acronym: CGRP (05 May 2002) |
| MAK-related kinase | <enzyme> A cdc2-related serine/threonine kinase; shows 87% idnetity to the male-germ cell associated kinase (mak); mw 66 kD; genbank d26178 Registry number: EC 2.7.10.- Synonym: mrk kinase (26 Jun 1999) |
| receptors, calcitonin gene-related peptide | Cell surface proteins that bind calcitonin gene-related peptide (cgrp) with high affinity and trigger intracellular changes which influence the behaviour of cells. Cgrp receptors are present in both the central nervous system and the periphery and are not the same as calcitonin receptors. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|